Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze TGTX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate TGTX investment potential.

What is TGTX stock price today?

Get real-time TGTX stock price, historical data, and price charts on Financhill. Track TGTX performance with our advanced analysis tools.

Is TGTX a good investment?

Evaluate TGTX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy TGTX stock?

To buy TGTX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of TGTX?

View detailed market capitalization data and company valuation metrics for TGTX on our comprehensive analysis page.

What is the P/E ratio of TGTX?

Use our fundamental analysis tools to view TGTX P/E ratio and compare valuation metrics with industry peers.

What are TGTX earnings?

View TGTX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

TG Therapeutics, Inc. Stock Predictions

This AI Layer Just Raised Its Share Price

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

TGTX
TG Therapeutics, Inc.

Last Price:

$31.37

Seasonality Move:

25.86%

7 Day Trial

ALL ACCESS PASS

$ 7

$0.85 Entry Open - Fortune 1000 AI Tech in Demand

TG Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, TG Therapeutics, Inc. has on average historically risen by 20.8% based on the past 29 years of stock performance.
TG Therapeutics, Inc. has risen higher in 13 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.83%
Is TG Therapeutics, Inc. Stock Undervalued?

The current TG Therapeutics, Inc. [TGTX] share price is $31.61. The Score for TGTX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
TGTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will TG Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, TG Therapeutics, Inc. has on average historically risen by 20.8% based on the past 29 years of stock performance.

TG Therapeutics, Inc. Stock Rating

Sell

TG Therapeutics, Inc. (TGTX) is a Sell

Is TG Therapeutics, Inc. overpriced?

TG Therapeutics, Inc. has risen higher in 13 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.83%

TG Therapeutics, Inc. Stock Price History

Is TGTX stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TGTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

tgtherapeutics.com

52-Week Data

52-Week High:

46.48

52-Week Low:

25.28

Prediction Charts

Market Cap:

Price in USD:

31.61

Volume:

1.5M

Beta:

0.92

Technical Analysis

SMA50:

33.67

SMA100:

32.81

SMA200:

34.92

52-Wk Change:

-5.33%

Stock Predictions

Is TG Therapeutics, Inc. stock public?

Yes, TG Therapeutics, Inc. is a publicly traded company.
What is the TG Therapeutics, Inc. stock quote today?

The TG Therapeutics, Inc. stock price is 31.61 USD today.
How to buy TG Therapeutics, Inc. stock online?

You can buy TG Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-13	30.81	30.95	31.78	30.76
Nov-14	30.98	31.00	31.50	30.65
Nov-17	31.02	30.68	31.42	30.31
Nov-18	30.52	31.20	31.45	30.24
Nov-19	31.25	30.33	31.40	30.23
Nov-20	30.70	30.46	30.96	30.15
Nov-21	30.40	31.95	32.11	30.32
Nov-24	32.25	32.03	33.05	31.93
Nov-25	32.49	32.98	33.05	32.28
Nov-26	32.87	33.43	33.79	32.50
Nov-28	33.61	33.26	33.61	32.91
Dec-1	32.73	31.66	32.80	31.61
Dec-2	31.53	30.63	31.68	30.54
Dec-3	30.61	31.61	31.79	30.58

TG Therapeutics, Inc. Earnings

TG Therapeutics, Inc. Earnings Report: Per Share TG Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

TG Therapeutics, Inc. Forecast Revenue Growth

TG Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for TG Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.69 per share, and a decrease next year of $0.95 per share.

* TG Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.